Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05809518Completed
Randomised, open-label trial of dexmedetomidine (3 arms), sponsored by Anesthesia Research Group. Primary endpoints: Hospital Length of Stay up to 20 days and ICU Length of Stay up to 7 days. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05809518.